AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.32 billion. The enterprise value is $3.40 billion.
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025, before market open.
Earnings Date | Feb 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 131.62 million shares outstanding. The number of shares has decreased by -0.81% in one year.
Current Share Class | 131.62M |
Shares Outstanding | 131.62M |
Shares Change (YoY) | -0.81% |
Shares Change (QoQ) | +0.37% |
Owned by Insiders (%) | 11.25% |
Owned by Institutions (%) | 77.86% |
Float | 78.30M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 10.45 |
PS Ratio | 0.41 |
Forward PS | 0.39 |
PB Ratio | 0.87 |
P/TBV Ratio | n/a |
P/FCF Ratio | 5.76 |
P/OCF Ratio | 2.42 |
PEG Ratio | 1.44 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 5.08, with an EV/FCF ratio of 14.82.
EV / Earnings | n/a |
EV / Sales | 1.04 |
EV / EBITDA | 5.08 |
EV / EBIT | 11.24 |
EV / FCF | 14.82 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.43.
Current Ratio | 1.24 |
Quick Ratio | 0.91 |
Debt / Equity | 1.43 |
Debt / EBITDA | 2.98 |
Debt / FCF | 9.50 |
Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is -12.88% and return on invested capital (ROIC) is 4.88%.
Return on Equity (ROE) | -12.88% |
Return on Assets (ROA) | 4.11% |
Return on Capital (ROIC) | 4.88% |
Revenue Per Employee | $304,913 |
Profits Per Employee | -$20,351 |
Employee Count | 10,700 |
Asset Turnover | 0.71 |
Inventory Turnover | 21.22 |
Taxes
In the past 12 months, AdaptHealth has paid $3.82 million in taxes.
Income Tax | 3.82M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +38.48% in the last 52 weeks. The beta is 1.09, so AdaptHealth's price volatility has been similar to the market average.
Beta (5Y) | 1.09 |
52-Week Price Change | +38.48% |
50-Day Moving Average | 9.94 |
200-Day Moving Average | 10.32 |
Relative Strength Index (RSI) | 54.30 |
Average Volume (20 Days) | 1,664,763 |
Short Selling Information
The latest short interest is 9.67 million, so 7.35% of the outstanding shares have been sold short.
Short Interest | 9.67M |
Short Previous Month | 10.12M |
Short % of Shares Out | 7.35% |
Short % of Float | 12.36% |
Short Ratio (days to cover) | 11.06 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.26 billion and -$217.76 million in losses. Loss per share was -$1.65.
Revenue | 3.26B |
Gross Profit | 611.45M |
Operating Income | 302.22M |
Pretax Income | -730.11M |
Net Income | -217.76M |
EBITDA | 669.38M |
EBIT | 302.22M |
Loss Per Share | -$1.65 |
Full Income Statement Balance Sheet
The company has $102.30 million in cash and $2.18 billion in debt, giving a net cash position of -$2.08 billion or -$15.78 per share.
Cash & Cash Equivalents | 102.30M |
Total Debt | 2.18B |
Net Cash | -2.08B |
Net Cash Per Share | -$15.78 |
Equity (Book Value) | 1.52B |
Book Value Per Share | 11.52 |
Working Capital | 130.77M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $546.69 million and capital expenditures -$317.37 million, giving a free cash flow of $229.32 million.
Operating Cash Flow | 546.69M |
Capital Expenditures | -317.37M |
Free Cash Flow | 229.32M |
FCF Per Share | $1.74 |
Full Cash Flow Statement Margins
Gross margin is 18.74%, with operating and profit margins of 9.26% and -6.57%.
Gross Margin | 18.74% |
Operating Margin | 9.26% |
Pretax Margin | -6.33% |
Profit Margin | -6.57% |
EBITDA Margin | 20.52% |
EBIT Margin | 9.26% |
FCF Margin | 7.03% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.81% |
Shareholder Yield | 0.81% |
Earnings Yield | -16.48% |
FCF Yield | 17.35% |
Dividend Details Analyst Forecast
The average price target for AdaptHealth is $12.40, which is 23.51% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.40 |
Price Target Difference | 23.51% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 1.05 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.05 |
Piotroski F-Score | 6 |